These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27430904)

  • 1. Establishing a control system using QbD principles.
    Kepert JF; Cromwell M; Engler N; Finkler C; Gellermann G; Gennaro L; Harris R; Iverson R; Kelley B; Krummen L; McKnight N; Motchnik P; Schnaible V; Taticek R
    Biologicals; 2016 Sep; 44(5):319-31. PubMed ID: 27430904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of critical quality attributes for monoclonal antibodies using quality by design principles.
    Alt N; Zhang TY; Motchnik P; Taticek R; Quarmby V; Schlothauer T; Beck H; Emrich T; Harris RJ
    Biologicals; 2016 Sep; 44(5):291-305. PubMed ID: 27461239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of QbD risk assessment tools and overall risk management.
    Kelley B; Cromwell M; Jerkins J
    Biologicals; 2016 Sep; 44(5):341-51. PubMed ID: 27461127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the application of QbD principles for the development of monoclonal antibodies.
    Finkler C; Krummen L
    Biologicals; 2016 Sep; 44(5):282-90. PubMed ID: 27546184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process characterization and Design Space definition.
    Hakemeyer C; McKnight N; St John R; Meier S; Trexler-Schmidt M; Kelley B; Zettl F; Puskeiler R; Kleinjans A; Lim F; Wurth C
    Biologicals; 2016 Sep; 44(5):306-18. PubMed ID: 27464992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QbD implementation and Post Approval Lifecycle Management (PALM).
    Ohage E; Iverson R; Krummen L; Taticek R; Vega M
    Biologicals; 2016 Sep; 44(5):332-40. PubMed ID: 27449920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
    Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
    J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical product development: A quality by design approach.
    Pramod K; Tahir MA; Charoo NA; Ansari SH; Ali J
    Int J Pharm Investig; 2016; 6(3):129-38. PubMed ID: 27606256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach.
    Eon-Duval A; Broly H; Gleixner R
    Biotechnol Prog; 2012; 28(3):608-22. PubMed ID: 22473974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
    Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
    J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by design (QbD) approaches in current pharmaceutical set-up.
    Mishra V; Thakur S; Patil A; Shukla A
    Expert Opin Drug Deliv; 2018 Aug; 15(8):737-758. PubMed ID: 30044646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of quality by design to the development of analytical separation methods.
    Orlandini S; Pinzauti S; Furlanetto S
    Anal Bioanal Chem; 2013 Jan; 405(2-3):443-50. PubMed ID: 22941176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design for herbal drugs: a feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes.
    Yan B; Li Y; Guo Z; Qu H
    Phytochem Anal; 2014; 25(1):59-65. PubMed ID: 24108478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Identification of Critical Quality Attributes (CQAs) for the Development of Antibody Drugs].
    Saitoh S
    Yakugaku Zasshi; 2018; 138(12):1475-1481. PubMed ID: 30504661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A design space exploration for control of Critical Quality Attributes of mAb.
    Bhatia H; Read E; Agarabi C; Brorson K; Lute S; Yoon S
    Int J Pharm; 2016 Oct; 512(1):242-252. PubMed ID: 27575657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality by Design: Concept to Applications.
    Swain S; Parhi R; Jena BR; Babu SM
    Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.